Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison.
A small proportion of hepatocellular carcinoma (HCC) patients are suitable for surgical resections and various minimally invasive procedures have been introduced as alternatives to surgical resections. However, the relative efficacy of minimally invasive procedures remains to be studied in the current literature. Several popular minimally invasive procedures (monotherapy or combined therapies) were selected for comparison and their relative long-term efficacy were determined by using the statistics of hazard ratio (HR) which evaluates the survival status of HCC patients in one, two, three and four years, respectively. Evidence were obtained from the current literature and synthesized by using the approach of conventional pairwise meta-analysis and network meta-analysis (NMA). Moreover, selected minimally invasive procedures were ranked according to their surface under the cumulative ranking curve (SUCRA) which was produced by NMA in conjunction with the Markov Chain Monte Carlo (MCMC) sampling method. HCC patients treated by combined minimally invasive procedures, particularly transcatheter arterial chemoembolization (TACE) + high intensity focused ultrasound (HIFU), TACE + radiofrequency ablation (RFA), TACE + radiotherapy (RT) and TACE + Sorafenib (SOR) exhibited a significant decrease in the HR compared to those with standard TACE (HR < 1). The combined minimally invasive procedure of TACE + HIFU appears to be the most preferable therapy. PEI seems to be less favorable than other minimally invasive procedures. Combined minimally invasive procedures may be more preferable than standard minimally invasive procedures. Percutaneous ethanol injection (PEI) may not provide adequate efficacy compared to other minimally invasive procedures for unresectable HCC patients.
Department of Gastroenterology, Huaihe Hospital of Henan University, Kaifeng, Henan, 475000, China.
Jianghai
J
Zhao
Department of Gastroenterology, Huaihe Hospital of Henan University, Kaifeng, Henan, 475000, China.
Hui
H
Zhang
Department of Gastroenterology, Huaihe Hospital of Henan University, Kaifeng, Henan, 475000, China.
Lunshou
L
Wei
Department of Gastroenterology, Huaihe Hospital of Henan University, Kaifeng, Henan, 475000, China.
Shuping
S
Xie
Department of Gastroenterology, Huaihe Hospital of Henan University, Kaifeng, Henan, 475000, China.
Zhimin
Z
Suo
D006801:Humans; D006528:Carcinoma, Hepatocellular / Q000628:therapy; D017115:Catheter Ablation; D016461:Chemoembolization, Therapeutic; D059248:Chemoradiotherapy; D003131:Combined Modality Therapy; D008113:Liver Neoplasms / Q000628:therapy; D015201:Meta-Analysis as Topic; D019060:Minimally Invasive Surgical Procedures; D011379:Prognosis
long-term efficacy; network meta-analysis; transarterial chemoembolization; unresectable hepatocellular carcinoma